home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

7.620 -0.200 (-2.56%)

Streaming Delayed Price Updated: 2:47 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2

...

24 25 26 27 28 29 30 31 Next >

Psychedelic Stock Gainers And Losers From February 9, 2022 ↗

February 09, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 14.29% at $5.76

Via Benzinga

Cathie Wood Is Buying this Peter Thiel-Backed Psychedelics Stock For Ark Funds ↗

February 09, 2022

There’s a new psychedelics company being added to an ETF from Cathie Wood. What Happened: The Ark Genomic Revolution ETF (BATS: ARKG) took an initial position in shares of...

Via Benzinga

Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today ↗

February 08, 2022

GAINERS: Awakn Life Sciences (OTC:AWKNF) shares closed up 3.51% at $1.62

Via Benzinga

Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗

February 07, 2022

GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 9.82% at $1.23

Via Benzinga

Is The Psychedelics Sector In Decline? This $30M VC Fund Says HOLD ↗

February 07, 2022

This article was originally published on Microdose and appears here with permission. Recently, there has been an exciting discussion in LinkedIn posts and Microdose PsyCap events regarding the presumed...

Via Benzinga

Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today ↗

February 04, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.29% at $0.20

Via Benzinga

Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

February 03, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.29% at $0.19

Via Benzinga

Mind Medicine, Allied Among Top Psychedelic Movers Of Today ↗

February 02, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 5.04% at $0.17

Via Benzinga

New Psychedelics ETF Launches On NYSE Arca ↗

February 02, 2022

Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)...

Via Benzinga

Mindset Pharma, Allied Among Top Psychedelic Movers Of Today ↗

February 01, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 15.70% at $0.69

Via Benzinga

ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today ↗

January 31, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.89% at $5.33

Via Benzinga

Has A Sugar Daddy Emerged In The Psychedelic Drug Industry? ↗

January 31, 2022

One very large drug multinational has already been active in writing checks to finance drug development in the psychedelic drug industry.

Via Talk Markets

The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January ↗

January 30, 2022

This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses.

Via Talk Markets

Psychedelic Stock Gainers And Losers From January 28, 2022 ↗

January 28, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 17.86% at $0.57

Via Benzinga

Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗

January 27, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 6.29% at $0.49

Via Benzinga

Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗

January 26, 2022

GAINERS: Small Pharma (OTC:

Via Benzinga

Mind Medicine, Mindset Pharma Among Top Psychedelic Movers Of Today ↗

January 25, 2022

GAINERS: Mind Medicine (NASDAQ:

Via Benzinga

Psychedelic Stock Gainers And Losers From January 24, 2022 ↗

January 24, 2022

GAINERS: Field Trip Health (NASDAQ:

Via Benzinga

Psyched: Eleusis To Go Public Via Merger, New Psychedelics Bills In Utah, Virginia, Kansas And Missouri ↗

January 24, 2022

Psychedelics Legalization Gains Momentum Around The Country: Bills Introduced In Utah, Virginia, Kansas And Missouri A wave of psychede...

Via Benzinga

Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD ↗

January 23, 2022

This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a...

Via Talk Markets

Psychedelic Stock Gainers And Losers From January 21, 2022 ↗

January 21, 2022

GAINERS: GH Research (NASDAQ:

Via Benzinga

Psychedelic Stock Gainers And Losers From January 20, 2022 ↗

January 20, 2022

GAINERS: Small Pharma (OTC:

Via Benzinga

Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today ↗

January 19, 2022

GAINERS: Revive Therapeutics (OTC:

Via Benzinga

Two-Thirds Of Physicians Say Psilocybin Therapy Can Help Treatment-Resistant Depression, New Survey Shows ↗

January 19, 2022

Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ:

Via Benzinga

Psilocybin and MDMA Get the Green Light for Medical Use in Canada

January 19, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – January 19, 2022 – After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of...

Via FinancialNewsMedia

Psychedelic Stock Gainers And Losers From January 18, 2022 ↗

January 18, 2022

GAINERS: Cybin (AMEX:

Via Benzinga

Psyched: Canada's Access To Psychedelic Medicines, Psilocybin No Cognitive Side Effects, Psilocybin Bill Washington ↗

January 10, 2022

Canada Opens New Legal Pathways For Access To Treatment With Psilocybin And MDMA In a groundbreaking decision, the Canadian gov...

Via Benzinga

A Recap of How Psychedelics Fared in 2021

January 07, 2022

Via Investor Brand Network

Psilocybin Does Not Produce Adverse Effects On Cognition Or Emotional Function, New Study Finds ↗

January 04, 2022

A new study is shedding light on the safety profile of psilocybin, the active ingredient in so-called “magic mushrooms.&rdqu...

Via Benzinga

Year-End Summary: Marijuana & Psychedelic Compounds-Based Drug Stocks Index Went DOWN -33.6% In 2021! ↗

January 02, 2022

Which index performed the best in 2021, the Marijuana Drug Stocks Index, or the Psychedelic Compounds-Based Drug Stocks Index? Which constituents contributed to their performances? This article has the...

Via Talk Markets

< Previous 1 2

...

24 25 26 27 28 29 30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com